A murine model of the cytotoxic T lymphocyte (CTL) response to glycoprotein B (gB) of human cytomegalovirus (HCMV) was developed based on the use of adenovirus (Ad) and vaccinia virus (Vac) recombinants expressing gB. Mice of different major histocompatibility haplotypes [CBA (H-2k), BALB/k (H-2 k) and BALB/c (H-2d)] infected with the Ad-gB recombinant developed an Ad-specific CTL response. However, only the H-2 k mice developed a significant HCMV gBspecific CTL response, as indicated by the major histocompatibility complex class I-restricted lysis of Vac strain Copenhagen (VacC)-gB recombinant-infected target cells by H-2 k mouse immune spleen cells. The VacC-gB recombinant elicited only a weak gB-specific CTL response in these mice, indicating that the observed gB-specific CTL response in mice is dependent on the expression vector used for immunization. The gBspecific cytotoxicity observed in H-2 k mice was mediated by the CD8 lymphocyte subset.
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Human cytomegalovirus (HCMV) is ubiquitous in humans, with usually mild or inapparent acute infection followed by persistence or latency in the host. However, HCMV is a significant cause of morbidity and mortality in infants infected in utero and in immunocompromised hosts (Weller, 1971; Glenn, 1981) .
Although the role of individual HCMV proteins in protective immunity is not completely understood, glycoprotein B (gB) is of interest because evidence suggests that it induces neutralizing antibody following natural infection (Britt et al., 1990; G6nczS1 et al., 1991) and following immunization with purified gB (G6ncz61 et al., 1990) . Moreover, human anti-gB monoclonal antibodies (MAbs) neutralize HCMV in vitro (Masuho et al., 1987) . There is also evidence for activation of helper T cells and cytotoxic T lymphocytes (CTLs) by gB in naturally seropositive humans (Borysiewicz et al., 1988; Liu et al., 199I ; Riddell et aI., 1991) . Finally, immunization of humans and experimental animals with purified gB induces lymphocytes that proliferate in the presence of gB in vitro (GSnczS1 et al., 1986b (GSnczS1 et al., , 1990 experiments, it has been demonstrated that animals infected with heterogeneous viral recombinants that express gB develop neutralizing antibody to HCMV (Britt et al., 1988; Cranage et al., 1986; G6nczS1 et al., 1991; Marshall et al., 1990) . In addition, adenovirus (Ad)-gB recombinant virus induces gB-specific helper T cells in BALB/c and CBA mice .
Recently recombinant viruses have been considered for use as vaccines for the prevention of viral diseases (Tartaglia et al., 1990) . In the present study, we asked whether recombinant viruses carrying the gB gene induce gB-specific CTL responses. As HCMV does not infect mice in vivo or murine tissue culture cells, we developed a model system suitable for the evaluation of CTL responses to individual HCMV proteins in mice. This model system is based on two types of viral expression vectors, vaccinia (Vac) and Ad virus, carrying the same HCMV gB gene and used alternately for immunization of mice or for infection of target cells to show that HCMV gB induces specific CTLs.
Ad and Vac recombinant viruses expressing the Towne strain gB were constructed previously. The Ad-gB recombinant expresses the gB gene under the control of the E3 promoter (Marshall et al., 1990) . In the Vac 0001-1860 © 1993 SGM Copenhagen strain gB recombinant (VacC-gB) the HCMV gB gene is under the control of the Vac H6 early/late promoter (G6ncz61 et al., 1991) . For use in immunization, recombinant or wild-type (wt) Ad or Vac were purified by CsC1 or sucrose gradient centrifugation, respectively. To test the ability of the Ad-gB recombinant to induce an HCMV gB-specific CTL response, T cell cytoxicity assays were performed, as described previously (Rawle et al., 1989) . Briefly, spleens of CBA mice immunized intraperitoneally (i.p.) with 108 p.f.u, of the Ad-gB recombinant virus or wt Ad were aseptically removed and cell suspensions were prepared from them. Cells were suspended at 2.5 × 10 ~ viable cells/ml in RPMI 1640 medium containing 5% fetal bovine serum, 2 × 10 -5 M-2-mercaptoethanol, 10 mM-HEPES buffer, 2 mM-glutamine and 50 ~tg/ml gentamicin. Spleen cell cultures were restimulated in vitro with Ad-gB-infected (m.o.i. 10) autologous spleen cells (effector:stimulator ratio 2: 1) for 5 days in 24-well plates. Cytolytic activity of non-adherent spleen cells was tested in a 51Cr release assay. Target cells (L-929, P815 and MC57) were infected with the E3-deleted Ad-5 mutant virus lacking the XbaI D fragment of virus DNA (Ad-5AE3) (m.o.i. 40 to 80, for 40 h) or with VacC-gB or wt VacC (m.o.i. 5 to 10, for 4 h). The Ad-5AE3 virus was constructed by overlap recombination, using plasmid pAd-5 containing map units (m.u.) 59.5 to 100 deleted in E3 sequences (m.u. 78-5 to 84), and pAd-5, m.u. 0 to 75-9, as described (Marshall et al., 1990 ). Cells were labelled with 100 ~tCi of [51Cr]Na2CrO~ (Amersham, specific activity 250 to 500 mCi/mg) for 1 h. Labelled target cells were mixed with effector cells at various effector:target (E:T) ratios in triplicate using 96-well U-bottomed microtitre plates and incubated for 4 h. Percentage specific 5~Cr release was calculated as [(c.p.m. experimental release-c.p.m. spontaneous release)/(c.p.m, maximal release-c.p.m. spontaneous release)] × 100. S.D. of the mean of triplicate culture was less than 10 %, and spontaneous release was always less than 25 %. As shown in Fig. 1 (a) , in vitro restimulated spleen cells from CBA mice immunized with Ad-gB induced no significant lysis of uninfected or wt Vac-infected major histocompatibility complex (MHC) class I-matched L-929 (H-2 k) target cells but did lyse Ad-5AE3-infected L-929 cells. HCMV gB-specific lysis of VacC-gB-infected L-929 target cells was determined to be 37, 36, 26 and 22 % at E:T ratios of 50: 1, 25 : 1, 12.5: 1 and 6: 1, respectively (Fig. 1 a) . The gB-specific lysis was calculated as percentage of specific lysis of VacC-gBinfected target cells-percentage of specific lysis of wt Vac-infected target cells. Mice immunized with wt Ad virus exhibited no gB-specific lysis of these target cells (Fig. 1 b) . VacC-gB-infected MHC-mismatched (H-2 b) MC57 target cells were not lysed by the splenocytes of Ad-gB-immunized mice (Fig. 1 a) . Spleen cells of nonimmunized mice restimulated in vitro with Ad-gB showed neither Ad-nor gB-specific cytotoxicity (data not shown). Thus Ad-gB-infected CBA mice generated not only Ad-specific CTLs, but also CTLs that specifically recognize gB expressed by VacC-gB in an MHC class I-restricted manner.
To determine whether the CBA mouse CTL response to gB was specific to the H-2 k haplotype, congenic BALB/c (H-2 d) and BALB/k (H-2 k) mice, which differ only in MHC haplotype, were inoculated i.p. with Ad-gB, and their spleen cells were tested for gB-specific lytic activity using P815 (H-2 d) and L929 (H-2 k) target cells. Ad-specific lysis was elicited by the spleen cells of both mouse strains (Fig. 1 c, d ). However, an HCMV gBspecific response was observed only in Ad-gB-immunized BALB/k mice, i.e. VacC-gB-infected target cells, but not wt Vac-infected L-929 cells, were specifically lysed (Fig. l c) . No gB-specific CTL response was observed in BALB/c mice ( Fig. 1 d) , demonstrating that H-2 k but not H-2 a mice recognize the gB antigen. The mouse strain-related difference in CTL response to gB is consistent with findings that immunogenicity of different viral proteins for the mouse CTL response varies with MHC haplotype (Tanaka et al., 1991) . Kinetic analysis of the gB-specific CTL response (Fig. 2) indicated that HCMV-gB-specific CTLs were present 1 week after immunization and remained detectable throughout the 12-week test period.
To characterize the cells responsible for anti-gB cytotoxicity, 3 x 106 in vitro restimulated spleen cells of Ad-gB-immunized mice were incubated with anti-mouse CD4 MAb (Pharmingen; cat. no. 3:01061D; 20 lag/3 x 106 cells) or CD8 MAb (Accurate; cat. no. CL-8921; diluted 1 : 4) for 60 min at 4 °C, and further incubated in the presence of rabbit complement (Accurate; Low-Tox M; diluted 1 : 10) for 30 min at 37 °C. Cells were washed twice and used as effector cells in a ~lCr release test. Almost no anti-gB activity was detected using CD8-depleted spleen cells, whereas CD4-depleted cells continued to mediate this activity (Table 1) . Thus the CD8 lymphocyte subset mediates the gB-specific lysis of the target cells.
The above results show that the Ad-gB recombinant can elicit an MHC class I-restricted CD8 lymphocytemediated HCMV gB-specific CTL response in mice and that by using our approach the CTL response to an individual HCMV antigen is readily detectable. However, the recognition of a CTL epitope by the immune system depends on the T cell repertoire of the individual and the structure of its MHC molecules. Some T cell epitopes are recognized by both human and mouse T cells (Hosmalin et al., 1990) . Although human CTLs recognize the gB protein at a low precursor frequency (Borysiewicz et al., 1988; Riddell et al., 1991) , it remains to be demonstrated that human and mouse CTLs recognize the same epitope on this protein.
To determine whether the CTL mouse model functions in the opposite direction, e.g. a gB-specific CTL response is induced in CBA mice immunized i.p. with VacC-gB, spleen cell cultures derived from these mice were tested for their gB-specific CTL activity. As restimulation of recombinant Vac-immune spleen cells with recombinant Vac may lead to a predominant response to Vac and difficulty detecting weaker CTL reponses to epitopes on the recombinant gene product, spleen cells from VacCgB-immunized CBA mice (108 p.f.u.) were pooled (cells from two mice from each group), divided in half and restimulated in vitro with VacC-gB (m.o.i. 0.5) or Ad-gB (m.o.i. 10) before testing for lyric ability on Ad-gB-, Ad-5AE3-, VacC-gB-and wt Vac-infected MHC class Imatched L-929 and mismatched MC57 target cells (Table  2) . In this assay, spleen cells of Ad-gB-immunized mice (108 p.f.u.) served as controls. It was observed that Ad-gB-immunized mice exhibited significant HCMV gB-specific cytolytic activity, regardless of the virus used for in vitro restimulation and for target cell infection, whereas the gB-specific CTL response observed after VacC-gB immunization was very low (< 10% in any combination of in vitro restimulation and target cell infection). The low CTL response associated with VacC gB does not reflect suboptimal experimental conditions since Vac-infected mice showed a high Vacspecific CTL response, and Ad-gB-immune spleen cells restimulated either with Ad-gB or VacC-gB elicited an identical gB-specific target cell lysis pattern. The studies on the comparative ability of CTL responses induced by an i.p. dose of 10Sp.f.u. of Ad-gB or VacGgB recombinant were performed five times with similar results. The gB-specific lysis obtained with VacC-gBimmune spleen cells was always significantly below the potency of the Ad-gB immune cells (Student's t-test, P ~< 0.01). It seems unlikely that the failure of the VacC-gB recombinant to elicit a significant CTL response rests in the lack of presentation of gB epitopes by the MHC molecules, since VacC-gB-infected target cells were readily lysed by Ad gB-primed mouse CTLs. Analysis in vivo in Ad gB-or VacC-gB-infected mice and the lack of gB-specific CTL may simply be the result of impaired gB expression in VacC-gB-immune CBA mice. Since gB is not a structural protein of the recombinant viruses, the formation of gB-specific antibody is a good indicator of gB expression in vivo. Therefore, the presence of HCMVneutralizing antibody in sera of VacC-gB-or Ad-gBimmunized mice was tested in a microneutralization assay (G6ncz61 et al., 1986a) . The results showed that both recombinant viruses induced neutralizing antibodies in CBA mice (1:54 or 1 : 124, mean titre of 10 mice immunized with VacC-gB or Ad-gB, respectively), indicating that gB is expressed in vivo in amounts sufficient to stimulate the immune system. In subsequent experiments, doses of 1 x 107, 5 x 107 or 1 x 109 p.f.u, of VacC-gB were used for immunization to exclude the possibility that 1 x 108 p.f.u, was not the optimal dose for CTL induction. Results showed the absence of CTL responses in mice immunized with lower than 1 x 108 p.f.u. Immunization with 1 x 109 p.f.u, or booster inoculation with 1 x 108 p.f.u., however, improved the gB-specific CTL response (14 to 21% or 15 to 17 % lysis, respectively at a 50: 1 E: T ratio), but remained below the gB-specific response induced by 1 x 108 p.f.u, of Ad-gB recombinant. Thus, we conclude that VacC-gB, although inducing a gB-specific neutralizing antibody response, is a poor CTL inducer for this immunogen. Various Vac recombinants, including Copenhagen strain recombi- 
